3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
20
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
2
Retinoblastoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinal Neoplasms
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Ovarian Cancer Recurrent
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Multiple Sclerosis
1
Melanoma
1
Lymphatic Metastasis
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Dermatomyositis
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Platinum Compounds
×
1 year
×
Clear all
No trials found.